Sale

Malaria Diagnostics Market

Global Malaria Diagnostics Market Share, Size, Growth, Research, Forecast: By Technology: Microscopy, Rapid Diagnostic Tests, Molecular Diagnostic Tests; By Treatment Channel: Public, Private; By End User: Hospitals, Clinics, Diagnostic Centres, Others; Market Dynamics: SWOT Analysis; Regional Analysis; Supplier Landscape; 2024-2032

Global Malaria Diagnostics Market Outlook

The global malaria diagnostics market size was around USD 811.82 million in 2023, driven by the increasing prevalence of malaria. The market is likely to grow at CAGR of 5.5% during the forecast period 2024-2032 to attain a value of USD 1,314.42 million by 2032.

 

Malaria Diagnostics Market: Introduction and Overview

Malaria refers to an intermittent and remittent fever caused by a protozoan parasite carried by female Anopheles mosquitoes that invades the red blood cells in the tropical and sub-tropical regions. Patients suffering from malaria often experience fever, chills, and flu-like symptoms. In patients infected by malaria, malaria causing parasite grows and multiplies first in the liver cells and then in the red blood cell. Malaria is usually curable, but it can become fatal if not taken care of properly. Malaria diagnostics refers to the process of identification of the parasite through blood smears under a microscope or through a rapid diagnostic test (RDT).

 

Global Malaria Diagnostics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on technology, the molecular diagnostic test segment is predicted to account for a substantial market share in the malaria diagnostics market. This increase can be associated with the high accuracy of these tests in detecting different variants of malaria-causing parasites. These tests are conducted in two ways, namely the polymerase chain reaction (PCR) and quantitative or real time-PCR (qPCR). These tests help detect low parasite counts and mixed infection cases. Moreover, these tests are incredibly sensitive and highly accurate even while detecting low levels of infections. Thus, this segment is estimated to positively catalyse the market growth over the forecast period.

 

Based on regions, Middle East and Africa is expected to occupy a substantial share of the malaria diagnostics market during the forecast period. This growth can be attributed to the growing prevalence of malaria in the region caused by the widespread malaria vector, Anopheles gambiae, which is difficult to control. According to the WHO statistics of 2019, the African region alone was home to 94% of all malaria cases and deaths worldwide.

 

Moreover, with the growing geriatric population who are more susceptible to such infections, governments are increasingly investing in the healthcare sector to reduce mortality risks associated with malaria. As a result, malaria diagnostics technology is witnessing a significant demand for the early detection of the disease. These factors are expected to contribute to the industry growth significantly.

 

Malaria Diagnostics Market Segmentations

 

Global Malaria Diagnostics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Breakup by Technology

  • Microscopy
  • Rapid Diagnostic Tests
  • Molecular Diagnostic Tests
    • Conventional PCR
    • Real-Time PCR

 

Market Breakup by Treatment Channel

  • Public
  • Private

 

Market Breakup by End User

  • Hospitals
  • Clinics
  • Diagnostic Centres
  • Others

 

Market Breakup by Region

  • North America
    • United States of America
    • Canada
  • Europe 
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific 
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America 
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa 
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others

 

Malaria Diagnostics Market Scenario

According to the WHO statistics of 2019, an estimated 299 million malaria cases were reported in the year, while the total number of deaths caused by malaria stood at 409 thousand in 2019. Out of these, children below five years of age accounted for 67% of all malaria-related deaths worldwide. This is due to the compromised immune system of children due to malnourishment and undernutrition.

 

Global Malaria Diagnostics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

In addition, children with severe malaria infection also show severe anaemia, respiratory issues concerning metabolic acidosis, or cerebral malaria. In the malaria endemic regions, the transmission speed of malaria increases with the longer life span of mosquitoes with a human-biting tendency. For instance, in Africa, the African vector mosquito species have a longer life span and are responsible for the 90% of the world's malaria cases. In this regard, countries worldwide and international organisations are introducing initiatives to control the spread and prevent malaria risks.

 

For instance, the WHO’s Global Malaria Programme and Malaria Consortium's Malaria Prevention and Control Project aim to prevent, protect, and treat children in collaboration with several countries such as Burkina Faso, Cameroon, the Democratic Republic of the Congo, Ghana, Mozambique. Such developments are expected to augment the market growth in the forecast period.

 

Competitive Landscape of the Global Malaria Diagnostics Market

The report gives a detailed analysis of the key players in the global malaria diagnostics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

 

  • ACCESS BIO. INC
  • Abbott
  • BioMérieux SA
  • Ortho Clinical Diagnostics
  • Thermo Fisher Scientific
  • PREMIER MEDICAL CORPORATION PVT LTD.
  • Siemens, Bio-Rad Laboratories, Inc.
  • Hemex Health
  • QuantuMDx Group Ltd.
  • Meridian Bioscience Europe B.V.
  • Intellectual Ventures Management LLC.
  • Novartis AG
  • BD
  • FYODOR BIOTECHNOLOGIES
  • Drucker Diagnostics
  • Danaher
  • Beckman Coulter, Inc.

 

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model and SWOT analysis.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Technology
  • Treatment Channel
  • End User
  • Region
Breakup by Technology
  • Microscopy
  • Rapid Diagnostic Tests
  • Molecular Diagnostic Tests
Breakup by Treatment Channel
  • Public
  • Private
Breakup by End User
  • Hospitals
  • Clinics
  • Diagnostic Centres
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • ACCESS BIO. INC
  • Abbott
  • BioMérieux SA
  • Ortho Clinical Diagnostics
  • Thermo Fisher Scientific
  • PREMIER MEDICAL CORPORATION PVT LTD.
  • Siemens, Bio-Rad Laboratories, Inc.
  • Hemex Health
  • QuantuMDx Group Ltd.
  • Meridian Bioscience Europe B.V.
  • Intellectual Ventures Management LLC.
  • Novartis AG
  • BD
  • FYODOR BIOTECHNOLOGIES
  • Drucker Diagnostics
  • Danaher
  • Beckman Coulter, Inc.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Malaria Diseases Overview 

    3.1    Guidelines and Stages
    3.2    Pathophysiology
    3.3    Screening and Diagnosis
    3.4    Treatment Pathway 
4    Patient Profile
    4.1    Patient Profile Overview
    4.2    Patient Psychology and Emotional Impact Factors
    4.3    Risk Assessment and Treatment Success Rate
5    Malaria Epidemiology Analysis
    5.1    Epidemiology Overview (2016-2031)
    5.2    North America Malaria Epidemiology (2016-2031)
    5.3    Europe Malaria Epidemiology (2016-2031)
    5.4    Asia Pacific Malaria Epidemiology (2016-2031)
    5.5    Latin America Malaria Epidemiology (2016-2031)
    5.6    Middle East and Africa Malaria Epidemiology (2016-2031)
6    Global Malaria Diagnostics Market Overview 
    6.1    Global Malaria Diagnostics Market Historical Value (2017-2023) 
    6.2    Global Malaria Diagnostics Market Forecast Value (2024-2032)
7    Global Malaria Diagnostics Market Landscape
    7.1    Global Malaria Diagnostics: Developers Landscape
        7.1.1    Analysis by Year of Establishment
        7.1.2    Analysis by Company Size
        7.1.3    Analysis by Region
    7.2    Global Malaria Diagnostics: Product Landscape
        7.2.1    Analysis by Technology
        7.2.2    Analysis by End User
        7.2.3    Analysis by Region
8    Malaria Challenges and Unmet Needs
    8.1    Treatment Pathway Challenges
    8.2    Compliance and Drop-Out Analysis
    8.3    Awareness and Prevention Gaps
9    Global Malaria Diagnostics Market Dynamics
    9.1    Market Drivers and Constraints
    9.2    SWOT Analysis
    9.3    Porter’s Five Forces Model
    9.4    Key Demand Indicators 
    9.5    Key Price Indicators
    9.6    Industry Events, Initiatives, and Trends  
    9.7    Value Chain Analysis
10    Global Malaria Diagnostics Market Segmentation
    10.1    Global Malaria Diagnostics Market by Technology
        10.1.1    Market Overview
        10.1.2    Microscopy
        10.1.3    Rapid Diagnostic Tests
        10.1.4    Molecular Diagnostic Tests
            10.1.4.1    Conventional PCR
            10.1.4.2    Real-Time PCR
    10.2    Global Malaria Diagnostics Market by Treatment Channel
        10.2.1    Market Overview
        10.2.2    Public
        10.2.3    Private
    10.3    Global Malaria Diagnostics Market by End User
        10.3.1    Market Overview
        10.3.2    Hospitals
        10.3.3    Clinics
        10.3.4    Diagnostic Centres
        10.3.5    Others
    10.4    Global Malaria Diagnostics Market by Region
        10.4.1    Market Overview
        10.4.2    North America
        10.4.3    Europe 
        10.4.4    Asia Pacific
        10.4.5    Latin America
        10.4.6    Middle East and Africa
11    North America Malaria Diagnostics Market
    11.1    Market Share by Country
    11.2    United States of America
    11.3    Canada
12    Europe Malaria Diagnostics Market
    12.1    Market Share by Country
    12.2    United Kingdom
    12.3    Germany
    12.4    France
    12.5    Italy
    12.6    Others
13    Asia Pacific Malaria Diagnostics Market
    13.1    Market Share by Country
    13.2    China
    13.3    Japan
    13.4    India
    13.5    ASEAN
    13.6    Australia
    13.7    Others
14      Latin America Malaria Diagnostics Market
    14.1    Market Share by Country
    14.2    Brazil
    14.3    Argentina
    14.4    Mexico
    14.5    Others
15    Middle East and Africa Malaria Diagnostics Market
    15.1    Market Share by Country
    15.2    Saudi Arabia
    15.3    United Arab Emirates
    15.4    Nigeria
    15.5    South Africa
    15.6    Others
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Patent  Analysis
    17.1    Analysis by Type of Patent
    17.2    Analysis by Publication year
    17.3    Analysis by Issuing Authority
    17.4    Analysis by Patent Age
    17.5    Analysis by CPC Analysis
    17.6    Analysis by Patent Valuation 
    17.7    Analysis by Key Players
18    Grants Analysis
    18.1    Analysis by year
    18.2    Analysis by Amount Awarded
    18.3    Analysis by Issuing Authority
    18.4    Analysis by Grant Application
    18.5    Analysis by Funding Institute
    18.6    Analysis by NIH Departments
    18.7    Analysis by Recipient Organization 
19    Clinical Trials Analysis
    19.1     Analysis by Trial Registration Year
    19.2    Analysis by Trial Status
    19.3    Analysis by Trial Phase
    19.4    Analysis by Therapeutic Area
    19.5    Analysis by Geography
20    Funding and Investment Analysis
    20.1    Analysis by Funding Instances
    20.2    Analysis by Type of Funding
    20.3    Analysis by Funding Amount
    20.4    Analysis by Leading Players
    20.5    Analysis by Leading Investors
    20.6    Analysis by Geography
21    Partnership and Collaborations Analysis
    21.1    Analysis by Partnership Instances
    21.2    Analysis by Type of Partnership
    21.3    Analysis by Leading Players
    21.4    Analysis by Geography
22    Supplier Landscape
    22.1    ACCESS BIO. INC
        22.1.1    Financial Analysis
        22.1.2    Product Portfolio
        22.1.3    Demographic Reach and Achievements
        22.1.4    Mergers and Acquisitions
        22.1.5    Certifications
    22.2     Abbott
        22.2.1    Financial Analysis
        22.2.2    Product Portfolio
        22.2.3    Demographic Reach and Achievements
        22.2.4    Mergers and Acquisitions
        22.2.5    Certifications
    22.3    BioMérieux SA
        22.3.1    Financial Analysis
        22.3.2    Product Portfolio
        22.3.3    Demographic Reach and Achievements
        22.3.4    Mergers and Acquisitions
        22.3.5    Certifications
    22.4    Ortho Clinical Diagnostics
        22.4.1    Financial Analysis
        22.4.2    Product Portfolio
        22.4.3    Demographic Reach and Achievements
        22.4.4    Mergers and Acquisitions
        22.4.5    Certifications
    22.5    Thermo Fisher Scientific
        22.5.1    Financial Analysis
        22.5.2    Product Portfolio
        22.5.3    Demographic Reach and Achievements
        22.5.4    Mergers and Acquisitions
        22.5.5    Certifications
    22.6    PREMIER MEDICAL CORPORATION PVT LTD.
        22.6.1    Financial Analysis
        22.6.2    Product Portfolio
        22.6.3    Demographic Reach and Achievements
        22.6.4    Mergers and Acquisitions
        22.6.5    Certifications
    22.7    Siemens, Bio-Rad Laboratories, Inc.
        22.7.1    Financial Analysis
        22.7.2    Product Portfolio
        22.7.3    Demographic Reach and Achievements
        22.7.4    Mergers and Acquisitions
        22.7.5    Certifications
    22.8    Hemex Health
        22.8.1    Financial Analysis
        22.8.2    Product Portfolio
        22.8.3    Demographic Reach and Achievements
        22.8.4    Mergers and Acquisitions
        22.8.5    Certifications
    22.9    QuantuMDx Group Ltd.
        22.9.1    Financial Analysis
        22.9.2    Product Portfolio
        22.9.3    Demographic Reach and Achievements
        22.9.4    Mergers and Acquisitions
        22.9.5    Certifications
    22.10    Meridian Bioscience Europe B.V.
        22.10.1    Financial Analysis
        22.10.2    Product Portfolio
        22.10.3    Demographic Reach and Achievements
        22.10.4    Mergers and Acquisitions
        22.10.5    Certifications
    22.11    Intellectual Ventures Management LLC.
        22.11.1    Financial Analysis
        22.11.2    Product Portfolio
        22.11.3    Demographic Reach and Achievements
        22.11.4    Mergers and Acquisitions
        22.11.5    Certifications
    22.12    Novartis AG
        22.12.1    Financial Analysis
        22.12.2    Product Portfolio
        22.12.3    Demographic Reach and Achievements
        22.12.4    Mergers and Acquisitions
        22.12.5    Certifications
    22.13    BD
        22.13.1    Financial Analysis
        22.13.2    Product Portfolio
        22.13.3    Demographic Reach and Achievements
        22.13.4    Mergers and Acquisitions
        22.13.5    Certifications
    22.14    FYODOR BIOTECHNOLOGIES
        22.14.1    Financial Analysis
        22.14.2    Product Portfolio
        22.14.3    Demographic Reach and Achievements
        22.14.4    Mergers and Acquisitions
        22.14.5    Certifications
    22.15    Drucker Diagnostics
        22.15.1    Financial Analysis
        22.15.2    Product Portfolio
        22.15.3    Demographic Reach and Achievements
        22.15.4    Mergers and Acquisitions
        22.15.5    Certifications
    22.16    Danaher
        22.16.1    Financial Analysis
        22.16.2    Product Portfolio
        22.16.3    Demographic Reach and Achievements
        22.16.4    Mergers and Acquisitions
        22.16.5    Certifications
    22.17    Beckman Coulter, Inc.
        22.17.1    Financial Analysis
        22.17.2    Product Portfolio
        22.17.3    Demographic Reach and Achievements
        22.17.4    Mergers and Acquisitions
        22.17.5    Certifications
23    Malaria  Diagnostics Market- Distribution Model (Additional Insight)
    23.1    Overview 
    23.2    Potential Distributors 
    23.3    Key Parameters for Distribution Partner Assessment 
24    Key Opinion Leaders (KOL) Insights (Additional Insight)
25    Company Competitiveness Analysis (Additional Insight)

    25.1    Very Small Companies
    25.2    Small Companies
    25.3    Mid-Sized Companies
    25.4    Large Companies
    25.5    Very Large Companies
26    Payment Methods (Additional Insight)
    26.1    Government Funded
    26.2    Private Insurance
    26.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The market attained a value of USD 811.82 million in 2023, driven by the rising cases of malaria.

The market is anticipated to grow at a CAGR of 5.5% during the forecast period of 2024-2032 to attain a value of USD 1,314.42 million by 2032.

The technologies used in the market include microscopy, rapid diagnostic tests, and molecular diagnostic tests. Molecular diagnostic tests can be further categorised into conventional PCR and real-time PCR.

The market uses public and private channels for treatment.

The end-users include hospitals, clinics, and diagnostic centres, among others.

The major regional markets include North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

The key players in the market include ACCESS BIO. INC, Abbott, BioMérieux SA, Ortho Clinical Diagnostics, Thermo Fisher Scientific, PREMIER MEDICAL CORPORATION PVT LTD., Siemens, Bio-Rad Laboratories, Inc., Hemex Health, QuantuMDx Group Ltd., Meridian Bioscience Europe B.V., Intellectual Ventures Management LLC., Novartis AG, BD, FYODOR BIOTECHNOLOGIES, Drucker Diagnostics, Danaher, and Beckman Coulter, Inc., among others.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER